139 related items for PubMed ID: 3032691
1. Opioid regulation of luteinizing hormone in amenorrheic patients after therapy for induction of ovulation.
Nappi C, Petraglia F, Di Meo G, Minutolo M, Genazzani AR, Montemagno U.
Fertil Steril; 1987 Apr; 47(4):579-83. PubMed ID: 3032691
[Abstract] [Full Text] [Related]
2. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME, Sheehan KL, Casper RF, Yen SS.
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[Abstract] [Full Text] [Related]
3. Endogenous opioid blockade and gonadotropin secretion: role of pulsatile luteinizing hormone-releasing hormone administration in anorexia nervosa and weight loss amenorrhea.
Giusti M, Torre R, Traverso L, Cavagnaro P, Attanasio R, Giordano G.
Fertil Steril; 1988 May; 49(5):797-801. PubMed ID: 3129313
[Abstract] [Full Text] [Related]
4. The effects of opiate antagonism on gonadotropin secretion in children and in women with hypothalamic amenorrhea.
Sauder SE, Case GD, Hopwood NJ, Kelch RP, Marshall JC.
Pediatr Res; 1984 Apr; 18(4):322-8. PubMed ID: 6326037
[Abstract] [Full Text] [Related]
5. Follicle-stimulating hormone is the main determinant of follicular recruitment and development in ovulation induction with human menopausal gonadotropin.
Vermesh M, Kletzky OA.
Am J Obstet Gynecol; 1987 Dec; 157(6):1397-402. PubMed ID: 3122575
[Abstract] [Full Text] [Related]
6. Gonadotropin-releasing hormone pacemaker sensitivity to negative feedback inhibition by estradiol in women with hypothalamic amenorrhea.
Judd S, Stranks S, Michailov L.
Fertil Steril; 1989 Feb; 51(2):257-62. PubMed ID: 2492233
[Abstract] [Full Text] [Related]
7. Ovulation induction in hypergonadotropic amenorrhea with estrogen and human menopausal gonadotropin therapy.
Check JH, Chase JS.
Fertil Steril; 1984 Dec; 42(6):919-22. PubMed ID: 6094261
[No Abstract] [Full Text] [Related]
8. Induction of ovulation in amenorrheic patients with gonadotropin-releasing hormone and human menopausal gonadotropin.
Eckstein N, Vagman I, Eshel A, Naor Z, Ayalon D.
Fertil Steril; 1985 Dec; 44(6):744-50. PubMed ID: 3935484
[Abstract] [Full Text] [Related]
9. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
Dawood MY, Jarrett JC, Choe JK.
Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
[Abstract] [Full Text] [Related]
10. The induction of ovulation in amenorrheic patients with synthetic luteinizing hormone-releasing hormone: the significance of pituitary responsiveness.
Huang KE.
Fertil Steril; 1976 Jan; 27(1):65-71. PubMed ID: 1107074
[Abstract] [Full Text] [Related]
11. Naloxone stimulation test in women with hypothalamic amenorrhea: a preliminary report.
Krause B, Møller S, Göretzlehner G, Ulrich U, Matuszewski F, Wodrig W, Weber A.
Exp Clin Endocrinol; 1992 Jan; 99(2):113-5. PubMed ID: 1322310
[Abstract] [Full Text] [Related]
12. Ovulation induction with luteinizing hormone--releasing hormone in amenorrheic, infertile women.
Hammond CB, Wiebe RH, Haney AF, Yancy SG.
Am J Obstet Gynecol; 1979 Dec 01; 135(7):924-39. PubMed ID: 389050
[Abstract] [Full Text] [Related]
13. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ, Bergquist C, Wide L.
Int J Fertil; 1980 Dec 01; 25(3):239-46. PubMed ID: 6108935
[Abstract] [Full Text] [Related]
14. Ovulation induction with pulsatile gonadotropin-releasing hormone (GnRH) or gonadotropins in a case of hypothalamic amenorrhea and diabetes insipidus.
Georgopoulos NA, Markou KB, Pappas AP, Protonatariou A, Vagenakis GA, Sykiotis GP, Dimopoulos PA, Tzingounis VA.
Gynecol Endocrinol; 2001 Dec 01; 15(6):421-5. PubMed ID: 11826765
[Abstract] [Full Text] [Related]
15. [The luliberin test as a criterion for assessing the prospect of stimulating ovulation with pergonal].
Manuilova IA, Nazarenko TA, Mullabaeva SM.
Probl Endokrinol (Mosk); 1990 Dec 01; 36(6):40-4. PubMed ID: 2128403
[Abstract] [Full Text] [Related]
16. Impairment of dopaminergic and opioidergic activity in patients with polycystic ovarian disease is restored by treatment for the induction of ovulation.
Nappi C, Petraglia F, Di Carlo C, De Rosa R, Zaccardo A, Genazzani AR, Montemagno U.
Gynecol Obstet Invest; 1989 Dec 01; 27(1):38-41. PubMed ID: 2920972
[Abstract] [Full Text] [Related]
17. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients.
Shoham Z, Balen A, Patel A, Jacobs HS.
Fertil Steril; 1991 Dec 01; 56(6):1048-53. PubMed ID: 1743320
[Abstract] [Full Text] [Related]
18. Effect of dexamethasone on gonadotropin responsiveness to luteinizing hormone-releasing hormone and clomiphene in women with secondary amenorrhea.
Sowers JR, Fayez J.
Am J Obstet Gynecol; 1979 Jun 01; 134(3):325-8. PubMed ID: 377969
[Abstract] [Full Text] [Related]
19. Plasma beta-endorphin levels in anovulatory states: changes after treatments for the induction of ovulation.
Petraglia F, Di Meo G, De Leo V, Nappi C, Facchinetti F, Genazzani AR.
Fertil Steril; 1986 Feb 01; 45(2):185-90. PubMed ID: 2936625
[Abstract] [Full Text] [Related]
20. Luteinizing hormone-releasing hormone (LH-RH) as a diagnostic and research tool in gynecologic endocrinology.
Taymor ML, Thompson IE, Berger MJ, Patton W.
Am J Obstet Gynecol; 1974 Nov 15; 120(6):721-32. PubMed ID: 4611213
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
